Nakasone, H., Terasako‐Saito, K., Hirano, T., Wake, A., Shimizu, S., Kurita, N., Yamazaki, E., Usuki, K., Akazawa, K., Kanda, J., Minauchi, K., Yamamoto, G., Tanimoto, S., Kamoshita, M., Yokoyama, Y., Miyaoka, E., Ota, S., Kako, S., Izutsu, K., & Kanda, Y. (2018). targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematological oncology, 36(1), 202–209. http://access.bl.uk/ark:/81055/vdc_100057158337.0x000056